ClinicalTrials.gg
Drug

Xelox clinical trials

studies test it
60
open now
31
in phase 3
10
first study started
2003

How each study uses xelox is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the xelox studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

XELOX
22
XELOX (Capecitabine and Oxaliplatin)
2
oxaliplatin and capecitabine
2

In one entry with another drug

Given together, or one or the other

CapeOX
6
XELOX + Bevacizumab
2
CapeOX + bevacizumab
2
CAPEOX/XELOX
2

Studies by the year they started

60 studies that test it; most in 2024 (8)

Studies that test xelox, by start year
YearStudies
20031
20063
20102
20111
20121
20132
20141
20162
20171
20185
20192
20205
20212
20224
20237
20248
20258
20265

By phase

A phase 1/2 study counts in both.

Phase 1
8
Phase 2
45
Phase 3
10
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 52

Harbin Medical University (4) · Fudan University (3) · West China Hospital (2) · Peking University Cancer Hospital & Institute (2) · AstraZeneca (2) · The First Affiliated Hospital with Nanjing Medical University (2) · Henan Cancer Hospital (2) · Tang-Du Hospital (2)

Often tested with

Tested in the same studies.

CAPOX Regimen (17) · Sintilimab (7) · Bevacizumab (6) · Folfox protocol (4) · XELIRI Regimen (4) · Modified FOLFOX Regimen (3) · Oxaliplatin (3) · FOLFOXIRI Regimen (3)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 5 phase 3 studies under way

Xelox is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 10

Studies that test xelox.

Studies

Open first, then newest update. How each study uses xelox is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 60

See all 60 studies that test xelox →

Given beside what is tested · 31 — xelox is usual care or a partner of the new treatment

Showing 20 of 31.

As the comparator · 14 — what is tested is compared with xelox